Eisai has submitted a new drug application to Japan’s PMDA seeking approval for Leqembi’s SC formulation, SC-AI, for early ...

West Pharmaceutical Services is the winner of the Product Launches Award for Prefillable Syringe Systems in the 2025 ...

Lupin has FDA approval for Armlupeg 6mg/0.6ml injection in a single-dose prefilled syringe, for subcutaneous use, as a ...

PrEP has become an important tool in preventing HIV infection, helping reduce the risk of contracting the virus by up to 99%; however, its use has been disrupted this year. The AIDS Vaccine Advocacy ...

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.

During the UK’s Autumn Budget, Rachel Reeves has unveiled further technology investments for the UK’s National Health Service ...

The proportion of children receiving a second dose of the MMR vaccine is still below the threshold to stop viral transmission ...

Otsuka Pharmaceutical has accelerated FDA approval for Voyxact to reduce proteinuria in adults with primary IgAN at disease ...

In 2024, over half of patients found to have HIV in Europe received a late diagnosis, which is often associated with poor ...

Not long after cutting its sales forecast for 2025, Valneva has decided to decrease its operational footprint in France by ...

Developed by UCL spinout Autolus, Aucatzyl will be launched imminently across England and Wales. A UK-developed cell therapy ...

The approval marks the first for a targeted treatment in chronic spontaneous urticaria in Europe in over a decad ...